S. Peters and G. Tortora present an overview of the 2015 programme. A deep analysis of the genetic landscape of tumours; new compounds under development; mechanisms of resistance and clinical applications will be presented to a varied audience interested in innovative ways to target this complex pathway, disregulated at different levels and present in the majority of tumours.